Tagged with P

China The Greater Bay Area’s – and in particular, Shenzhen’s – prowess in life sciences manufacturing and development must also be attributed to the decades of experience and expertise gained from acting as OEM/ODM to global companies, in line with China’s overall positioning as the world’s factory floor. One of the…

Innovation Joonho J. Lee is a CEO and CoFounder of Cognita Lab INC developing risk management framework around Artificial Intelligence (AI) in healthcare and financial services industries. Here he discusses the use of blockchain in the healthcare industry and the need to remain “cautiously optimistic.”   Many people asked whether I…

Spain Baltasar Lobato, managing partner of health and life sciences at EY Spain, highlights the major market trends affecting the public and private healthcare sector as well as the pharmaceutical market. He also gives an overview of the complex nature of the Spanish market, the importance of IT in creating a…

EUROPE The latest EFPIA data on the VAT rates applied to medicines in European countries in 2018.

Spain The global rich list is splattered with household names who have built their reputation not only through business acumen but through eye-catching purchases such as Steve Balmer’s record buyout of the LA Clippers basketball team for a whopping USD two billion in 2016 or Roman Abramovich´s spectacular 162.5 metres yacht…

Spain LEO Pharma’s Paolo Cionini discusses recent structural changes in the dermatology specialist’s Europe South operations, the importance of Spain to the regional group, and the nation’s digital capabilities.   The biggest need in Europe and the US is around new products and technologies in advanced therapies. LEO Pharma has undergone…

Patients At the 2018 Financial Times Pharmaceutical and Biotechnology Conference, there was a lot of buzz around ‘patient centricity’ and all of the big pharma companies were determined to broadcast their goals of having patients at front and centre throughout their business. Over the past decade, we have seen a dramatic…

Digital Health Rhenu Bhuller, a founding member of Frost & Sullivan’s Asia Pacific operations and expert in analysing the impact of cutting-edge tech, looks at pharma’s evolution and adoption of digital health.   The evolution of disease management and the convergence of drugs, devices and digital health in the management of various…

Turkey Abidin Gulmus, founder and chairman of Gen Ilaç, describes the company’s impressive journey to become Turkey’s principle orphan drug distributor and shares his vision for leveraging the company’s domestic expertise to expand their reach into foreign markets.   Gen Ilaç is one of the fastest growing Turkish success stories although…

Innovation Carla Smith, Executive Vice President of The Healthcare Information and Management Systems Society (HIMSS) discusses the need to adopt innovation and retrain the workforce to provide healthcare without walls. If we are short-sighted and base our future workforce projections upon outdated models, we will experience a significant shortage in the…

Korea Jongmoon Kim, CEO of ToolGen discusses the potential for their CRISPR technology to revolutionize not only therapy for genetic illnesses, but also agriculture. Kim explains his move from information technology to biotechnology and the importance of building international partnerships across the industry.   CRISPR simplifies some of the complex tasks…

Canada Brian Hilberdink, President of Novo Nordisk Canada, calls for collaboration between government and industry to ensure that Canadian patients get swift access to the best treatments.    As a Canadian who spent several years working globally for a biopharmaceutical company, I saw firsthand how pricing and investment decisions can be made…